Jarden analyst Adrian Allbon maintained a Sell rating on Fisher & Paykel Healthcare Corporation Limited (FSPKF – Research Report) on March 22. The company’s shares closed last Friday at $15.28.
Powered by WPeMatico
Recent Posts
- Amazon software engineer who gives mock interviews shares advice for breaking into Big Tech October 22, 2024
- Advancements in Dental Technology Provide an Exceptional Patient Experience at Same Day Smiles October 22, 2024
- Harris’ Healthcare Plans And Trump’s Concepts Of A Plan: Implications For Patient Access October 22, 2024